Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
Publication Number | Title | Priority Date |
---|---|---|
US-2022009906-A1 | Isoindolin-1-one derivatives useful as grk2 inhibitors | 2020-06-24 |
BR-112020026545-A2 | HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR THE TREATMENT OF HUNTINGTON'S DISEASE | 2018-06-27 |
CN-112654625-A | Heterocyclic and heteroaryl compounds for the treatment of huntington's disease | 2018-06-27 |
KR-20210042265-A | Heterocyclic and heteroaryl compounds for the treatment of Huntington's disease | 2018-06-27 |
US-2021238186-A1 | Heterocyclic and heteroaryl compounds for treating huntington's disease | 2018-06-27 |
JP-2020500194-A | 5,6-Dihydro-11H-indolo [2,3-B] quinolin-11-one as ALK inhibitor | 2016-11-18 |
JP-2019528307-A | Aminopyrimidines as ALK inhibitors | 2016-08-29 |
US-2019175595-A1 | Aminopyrimidines as alk inhibitors | 2016-08-29 |
US-10709705-B2 | Aminopyrimidines as ALK inhibitors | 2016-08-29 |
US-2020330464-A1 | Aminopyrimidines as alk inhibitors | 2016-08-29 |